Literature DB >> 20022906

Analysis of cross-reactive and specific anti-carbohydrate antibodies against lipopolysaccharide from Chlamydophila psittaci.

Sandra Gerstenbruch1, Cory L Brooks, Paul Kosma, Lore Brade, C Roger Mackenzie, Stephen V Evans, Helmut Brade, Sven Müller-Loennies.   

Abstract

Chlamydiae contain a rough-type lipopolysaccharide (LPS) of 3-deoxy-alpha-d-manno-oct-2-ulopyranosonic acid residues (Kdo). Two Kdo trisaccharides, 2.8/2.4- and 2.4/2.4-linked, and a branched 2.4[2.8]2.4-linked Kdo tetrasaccharide occur in Chlamydiaceae. While the 2.8/2.4-linked trisaccharide contains a family-specific epitope, the branched Kdo oligosaccharide occurs only in Chlamydophila psittaci and antibodies against it will be useful in human and veterinarian diagnostics. To overcome the generation of cross-reactive antibodies that bind with high affinity to a dominant epitope formed by 2.4/2.4-linked Kdo, we immunized mice with a synthetic 2.4[2.8]-linked branched Kdo trisaccharide and used phage display of scFv to isolate recombinant antibody fragments (NH2240-31 and SAG506-01) that recognize the branched Kdo oligosaccharide with a K(D) of less than 10 nM. Importantly, although these antibodies used germline genes coding for an inherited Kdo recognition site, they were able clearly to distinguish between 2.4[2.8]2.4- and 2.4/2.4-linked Kdo. Sequence determination, binding data, and X-ray structural analysis revealed the basis for the improved discrimination between similar Kdo ligands and indicated that the alteration of a stacking interaction from a phenylalanine residue in the center of the combining site to a tyrosine residue facing away from the center favors recognition of branched 2.4[2.8]2.4-linked Kdo residues. Immunofluorescence tests of infected cell monolayers using this antibody show specific staining of C. psittaci elementary bodies that allow it to be distinguished from other pathogenic chlamydiae.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20022906      PMCID: PMC3058175          DOI: 10.1093/glycob/cwp198

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  29 in total

1.  Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains.

Authors:  K R Abhinandan; Andrew C R Martin
Journal:  Mol Immunol       Date:  2008-07-09       Impact factor: 4.407

2.  Pseudo-symmetry and twinning in crystals of homologous antibody Fv fragments.

Authors:  Cory L Brooks; Ryan J Blackler; Sandra Gerstenbruch; Paul Kosma; Sven Müller-Loennies; Helmut Brade; Stephen V Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2008-11-18

3.  A monoclonal antibody against a carbohydrate epitope in lipopolysaccharide differentiates Chlamydophila psittaci from Chlamydophila pecorum, Chlamydophila pneumoniae, and Chlamydia trachomatis.

Authors:  Sven Müller-Loennies; Sabine Gronow; Lore Brade; Roger MacKenzie; Paul Kosma; Helmut Brade
Journal:  Glycobiology       Date:  2005-11-10       Impact factor: 4.313

4.  Antibodies raised against chlamydial lipopolysaccharide antigens reveal convergence in germline gene usage and differential epitope recognition.

Authors:  Cory L Brooks; Sven Müller-Loennies; Svetlana N Borisova; Lore Brade; Paul Kosma; Tomoko Hirama; C Roger Mackenzie; Helmut Brade; Stephen V Evans
Journal:  Biochemistry       Date:  2010-01-26       Impact factor: 3.162

5.  High-throughput carbohydrate microarray profiling of 27 antibodies demonstrates widespread specificity problems.

Authors:  Joseph C Manimala; Timothy A Roach; Zhitao Li; Jeffrey C Gildersleeve
Journal:  Glycobiology       Date:  2007-05-04       Impact factor: 4.313

6.  The role of CDR H3 in antibody recognition of a synthetic analog of a lipopolysaccharide antigen.

Authors:  Cory L Brooks; Ryan J Blackler; Georg Sixta; Paul Kosma; Sven Müller-Loennies; Lore Brade; Tomoko Hirama; C Roger MacKenzie; Helmut Brade; Stephen V Evans
Journal:  Glycobiology       Date:  2009-09-18       Impact factor: 4.313

7.  Exploration of specificity in germline monoclonal antibody recognition of a range of natural and synthetic epitopes.

Authors:  Cory L Brooks; Sven Müller-Loennies; Lore Brade; Paul Kosma; Tomoko Hirama; C Roger MacKenzie; Helmut Brade; Stephen V Evans
Journal:  J Mol Biol       Date:  2008-01-16       Impact factor: 5.469

8.  Engineering antibody heavy chain CDR3 to create a phage display Fab library rich in antibodies that bind charged carbohydrates.

Authors:  Sonia Schoonbroodt; Mieke Steukers; Malini Viswanathan; Nicolas Frans; Marie Timmermans; Anita Wehnert; Minh Nguyen; Robert Charles Ladner; René M Hoet
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

9.  IMGT, the international ImMunoGeneTics information system.

Authors:  Marie-Paule Lefranc; Véronique Giudicelli; Chantal Ginestoux; Joumana Jabado-Michaloud; Géraldine Folch; Fatena Bellahcene; Yan Wu; Elodie Gemrot; Xavier Brochet; Jérôme Lane; Laetitia Regnier; François Ehrenmann; Gérard Lefranc; Patrice Duroux
Journal:  Nucleic Acids Res       Date:  2008-10-31       Impact factor: 16.971

10.  IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis.

Authors:  Xavier Brochet; Marie-Paule Lefranc; Véronique Giudicelli
Journal:  Nucleic Acids Res       Date:  2008-05-24       Impact factor: 16.971

View more
  13 in total

1.  The Potential Role of Solvation in Antibody Recognition of the Lewis Y Antigen.

Authors:  Somdutta Saha; Ramachandran Murali; Anastas Pashov; Thomas Kieber-Emmons
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-10

2.  Groove-type recognition of chlamydiaceae-specific lipopolysaccharide antigen by a family of antibodies possessing an unusual variable heavy chain N-linked glycan.

Authors:  Omid Haji-Ghassemi; Sven Müller-Loennies; Radka Saldova; Mohankumar Muniyappa; Lore Brade; Pauline M Rudd; David J Harvey; Paul Kosma; Helmut Brade; Stephen V Evans
Journal:  J Biol Chem       Date:  2014-03-28       Impact factor: 5.157

Review 3.  Peptide-displaying phage technology in glycobiology.

Authors:  Michiko N Fukuda
Journal:  Glycobiology       Date:  2011-09-19       Impact factor: 4.313

4.  Therapeutic Antibodies to Ganglioside GD2 Evolved from Highly Selective Germline Antibodies.

Authors:  Eric Sterner; Megan L Peach; Marc C Nicklaus; Jeffrey C Gildersleeve
Journal:  Cell Rep       Date:  2017-08-15       Impact factor: 9.423

5.  Exploring the cross-reactivity of S25-2: complex with a 5,6-dehydro-Kdo disaccharide.

Authors:  Cory L Brooks; Kurt Wimmer; Paul Kosma; Sven Müller-Loennies; Lore Brade; Helmut Brade; Stephen V Evans
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-12-25

6.  Bactericidal monoclonal antibodies specific to the lipopolysaccharide O antigen from multidrug-resistant Escherichia coli clone ST131-O25b:H4 elicit protection in mice.

Authors:  Valéria Szijártó; Luis M Guachalla; Zehra C Visram; Katharina Hartl; Cecília Varga; Irina Mirkina; Jakub Zmajkovic; Adriana Badarau; Gerhild Zauner; Clara Pleban; Zoltán Magyarics; Eszter Nagy; Gábor Nagy
Journal:  Antimicrob Agents Chemother       Date:  2015-03-16       Impact factor: 5.191

7.  Synthesis of chlamydia lipopolysaccharide haptens through the use of α-specific 3-iodo-Kdo fluoride glycosyl donors.

Authors:  Barbara Pokorny; Paul Kosma
Journal:  Chemistry       Date:  2014-10-29       Impact factor: 5.236

Review 8.  Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.

Authors:  Kristian Daniel Ralph Roth; Esther Veronika Wenzel; Maximilian Ruschig; Stephan Steinke; Nora Langreder; Philip Alexander Heine; Kai-Thomas Schneider; Rico Ballmann; Viola Fühner; Philipp Kuhn; Thomas Schirrmann; André Frenzel; Stefan Dübel; Maren Schubert; Gustavo Marçal Schmidt Garcia Moreira; Federico Bertoglio; Giulio Russo; Michael Hust
Journal:  Front Cell Infect Microbiol       Date:  2021-07-07       Impact factor: 5.293

9.  Surface Plasmon Resonance Analysis Shows an IgG-Isotype-Specific Defect in ABO Blood Group Antibody Formation in Patients with Common Variable Immunodeficiency.

Authors:  Michael B Fischer; Wendelin Wolfram; Christoph J Binder; Georg A Böhmig; Markus Wahrmann; Martha M Eibl; Hermann M Wolf
Journal:  Front Immunol       Date:  2015-05-06       Impact factor: 7.561

Review 10.  Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens.

Authors:  Nicola Clementi; Nicasio Mancini; Laura Solforosi; Matteo Castelli; Massimo Clementi; Roberto Burioni
Journal:  Int J Mol Sci       Date:  2012-07-04       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.